A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors (Q44100795)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in August 2002

Language	Label	Description	Also known as
English	A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors	scientific article published in August 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

author name string

Wei Lemaire

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Julie A O'Brien

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Maryann Burno

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Ashok G Chaudhary

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dennis C Dean

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Peter D Williams

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Roger M Freidinger

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Douglas J Pettibone

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

David L Williams

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

450

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

19-28

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Central functions of oxytocin

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Vasopressin and oxytocin receptors in the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Molecular cloning of the receptor for human antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Cloning and characterization of the human V3 pituitary vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Central nervous system effects of the neurohypophyseal hormones and related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Oxytocin receptors in nonpregnant human uterus.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

The oxytocin receptor system: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Structure and expression of a human oxytocin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihdyro-2(1H)-quinolinone

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Cloning and expression of the rhesus monkey oxytocin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

The brain oxytocin receptor(s)?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902048-4

7 January 2021

Identifiers

10.1016/S0014-2999(02)02048-4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44100795&oldid=2106594960"